Prophylactic bilateral mastectomy for breast cancer prevention

Journal of Women's Health

Volumn 13, Issue 7, 2004, Pages 822-829

  Metcalfe, Kelly A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; DECISION MAKING; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MASTECTOMY; PATIENT COUNSELING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSOCIAL DISORDER; REVIEW; RISK BENEFIT ANALYSIS;

ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASTECTOMY, MODIFIED RADICAL; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH;

EID: 5644274210     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2004.13.822     Document Type: Review

References (41)

1. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1 mutation carriers. Lancet 1994;343:692.
2. Reintgen D, Giulian A, Klimberg V, Society of Surgical Oncology. Position Statement on Prophylactic Mastectomy. Society of Surgical Oncology, 2001.
3. Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA. Prophylactic bilateral mastectomy: Patterns of practice. Cancer 2002;95:236.
4. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77.
5. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 2002;94:1564.
6. Morris KT, Johnson N, Krasikov N, Allen M, Dorsey P. Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer. Am J Surg 2001;181:431.
7. van Dijk S, Otten W, Zoeteweij MW, et al. Genetic counselling and the intention to undergo prophylactic mastectomy: Effects of a breast cancer risk assessment. Br J Cancer 2003;88:1675.
8. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879.
9. Goodnight JE, Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 1984;26:198.
10. Eldar S, Meguid MM, Beatty JD. Cancer of the breast after subcutaneous mastectomy. Am J Surg 1984; 148:692.
11. Zeigler LD, Krole SS. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol 1991;14:451.
12. Jameson MB, Roberts E, Nixon J, Probert JC, Braatvedt GD. Metastatic breast cancer 42 years after bilateral subcutaneous mastectomies. Clin Oncol (R Coll Radiol) 1997;9:119.
13. Willemsen H, Kaas R, Rutgers E. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol 1998;24:331.
14. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633.
15. Meijers-Heijboer M, VanGeel B, VanPutten W, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:158.
16. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336: 1465.
17. Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: An updated decision analysis. J Clin Oncol 2002;20:2520.
18. van Roosmalen MS, Verhoef LC, Stalmeier PF, Hoogerbrugge N, van Daal WA. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: A more prominent role for oophorectomy. J Clin Oncol 2002;20:2092.
19. Grann V. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 1998;16:979.
20. Grann VR, Jacobson JS, Whang W, et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2 positive women: A decision analysis. Cancer J Sci Am 2000;6:13.
21. Meiser B, Butow P, Friedlander M, et al. Intention to undergo prophylactic bilateral mastectomy in women with an increased risk of developing hereditary breast cancer. J Clin Oncol 2000;18:2250.
22. Stefanek M, Enger C, Benkendorf J, Flamm Honig S, Lerman C. Bilateral prophylactic mastectomy decision making: A vignette study. Prev Med 1999;29:216.
23. Lynch H, Lemon S, Durham C, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997;79:2219.
24. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 2000;37:866.
25. Lodder LN, Frets PG, Trijsburg RWC, et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2 Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002;73:97.
26. Wagner TM, Moslinger R, Langbauer GA, et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 2000;82:1249.
27. Lerman C, Hughes C, Croyle RT, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 2000;31:75.
28. Julian-Reynier CM, Bouchard LJ, Evans DG, et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: Differences among English, French, and Canadian women. Cancer 2001;92:959.
29. Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 2003;118A:201.
30. Houn F, Helzlsouer KJ, Friedman NB, Stefanek ME. The practice of prophylactic mastectomy: A survey of Maryland surgeons. Am J Public Health 1995;85:801.
31. Julian-Reynier C, Eisinger F, Moatti JP, Sobol H. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines. Eur J Hum Genet 2000;8:204.
32. Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484.
33. Bebbington Hatcher M, Fallowfield L. A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast 2003;12:1.
34. Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. Br Med J 2001;322:76.
35. Frost MH, Schaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 2000;284:319.
36. Metcalfe KA, Esplen MJ, Goel V, Narod S. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology 2004;13:14.
37. Hopwood P, Lee A, Shenton A, et al. Clinical followup after bilateral risk reducing ("prophylactic") mastectomy: Mental health and body image outcomes. Psychooncology 2000;9:462.
38. Borgen PI, Hill AD, Tran KN, et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 1998;5:603.
39. Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ. Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 2000;7:150.
40. Lloyd SM, Watson M, Oaker G, Sacks N, Querci della Rovere U, Gui G. Understanding the experience of prophylactic bilateral mastectomy: A qualitative study of ten women. Psychooncology 2000;9:473.
41. Josephson U, Wickman M, Sandelin K. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: A retrospective study. Eur J Surg Oncol 2000;26:351.